{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:05:59Z","timestamp":1786993559225,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jtocrr.2022.100375","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T12:07:29Z","timestamp":1657022849000},"page":"100375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparing Survival in Patients With Lung Cancer With and Without a History of Common Autoimmune Disease"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-9465","authenticated-orcid":false,"given":"Demitrios","family":"Dedousis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia N.","family":"Vassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthi","family":"Yammani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi K.","family":"Kyasaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Shanahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Keinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda L.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingfu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Dowlati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2022.100375_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jtocrr.2022.100375_bib2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/BOR.0000000000000648","article-title":"Malignancies in systemic lupus erythematosus: an update","volume":"31","author":"Ladouceur","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jtocrr.2022.100375_bib3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/0961203316688783","article-title":"Can killers be saviors?","volume":"26","author":"Singh","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jtocrr.2022.100375_bib4","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.autrev.2017.10.012","article-title":"The roles and applications of autoantibodies in progression, diagnosis, treatment and prognosis of human malignant tumours","volume":"16","author":"Wu","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtocrr.2022.100375_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10549-016-3801-4","article-title":"Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer","volume":"157","author":"Tabuchi","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jtocrr.2022.100375_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/271067a0","article-title":"Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors","volume":"271","author":"Alarcon-Segovia","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.jtocrr.2022.100375_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/art.1780300610","article-title":"Monoclonal murine anti-DNA antibody interacts with living mononuclear cells","volume":"30","author":"Okudaira","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtocrr.2022.100375_bib8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbrc.2018.01.139","article-title":"Re-engineering and evaluation of anti-DNA autoantibody 3E10 for therapeutic applications","volume":"496","author":"Rattray","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtocrr.2022.100375_bib9","doi-asserted-by":"crossref","first-page":"157ra142","DOI":"10.1126\/scitranslmed.3004385","article-title":"Targeting cancer with a lupus autoantibody","volume":"4","author":"Hansen","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtocrr.2022.100375_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.berh.2019.03.011","article-title":"Malignancy and rheumatoid arthritis: epidemiology, risk factors and management","volume":"32","author":"De Cock","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jtocrr.2022.100375_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102927","article-title":"Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis","volume":"51","author":"Ge","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jtocrr.2022.100375_bib12","first-page":"1704","article-title":"Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans","volume":"35","author":"Khurana","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jtocrr.2022.100375_bib13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","article-title":"Non-small cell lung cancer, version 5.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Ettinger","year":"2017","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.jtocrr.2022.100375_bib14","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.6004\/jnccn.2021.0058","article-title":"Small cell lung cancer, version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Ganti","year":"2021","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.jtocrr.2022.100375_bib15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jamaoncol.2016.2238","article-title":"Prevalence of autoimmune disease among patients with lung cancer: implications for immunotherapy treatment options","volume":"2","author":"Khan","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtocrr.2022.100375_bib17","series-title":"AJCC Cancer Staging Manual","author":"Greene","year":"2002"},{"key":"10.1016\/j.jtocrr.2022.100375_bib18","series-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2010"},{"key":"10.1016\/j.jtocrr.2022.100375_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jtocrr.2022.100375_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and Life-Tables","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0R Stat Soc B"},{"key":"10.1016\/j.jtocrr.2022.100375_bib21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jtocrr.2022.100375_bib22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.jtocrr.2022.100375_bib23","article-title":"The prevalence of autoimmune disorders in women: a narrative review","volume":"12","author":"Angum","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jtocrr.2022.100375_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtocrr.2022.100375_bib25","series-title":"Harrison\u2019s Principles of Internal Medicine, 20e","article-title":"Rheumatoid arthritis","author":"Shah","year":"2018"},{"key":"10.1016\/j.jtocrr.2022.100375_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12885-016-2444-5","article-title":"Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis","volume":"16","author":"Park","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtocrr.2022.100375_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29917","article-title":"Lung cancer survival in patients with autoimmune disease","volume":"3","author":"Jacob","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtocrr.2022.100375_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lungcan.2017.11.024","article-title":"How does autoimmune disease impact treatment and outcomes among patients with lung cancer? A national SEER-Medicare analysis","volume":"115","author":"Khan","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2022.100375_bib29","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/art.10897","article-title":"Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification","volume":"48","author":"Rasch","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtocrr.2022.100375_bib30","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":"The prevalence and geographic distribution of Crohn\u2019s disease and ulcerative colitis in the United States","volume":"5","author":"Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jtocrr.2022.100375_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0961203319888691","article-title":"Prevalence and incidence of systemic lupus erythematosus and associated outcomes in the 2009\u20132016 US Medicare population","volume":"29","author":"Li","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.jtocrr.2022.100375_bib33","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.15585\/mmwr.mm6946a4","article-title":"Tobacco product use among adults \u2014 United States, 2019","volume":"69","author":"Cornelius","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322000996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322000996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:37:24Z","timestamp":1762987044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364322000996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2666364322000996"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100375","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing Survival in Patients With Lung Cancer With and Without a History of Common Autoimmune Disease","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100375"}}